Immunophenotyping revealed an increase in intra-tumoral activated CD8+ T cells and conventional CD4+ T cells, along with a decrease in Tregs, indicating a shift from an immunosuppressive to a responsive tumor microenvironment and triggering a robust adaptive immune response [112]. This evidence concerns the gene CD4 and neoplasm.